Navigation Links
University Evaluates New Device To Treat Brain Tumors

The University of Illinois at Chicago has enrolled the first patient in the United States in a study of a new treatment for the most common and aggressive type of brain// tumor.

The international, multi-center trial will compare the best standard treatments -- surgical removal of the tumor, radiotherapy or chemotherapy -- to that treatment combined with a new, noninvasive therapy that provides alternating electrical fields directly to the surface of the head.

"This therapy is a totally novel approach that is, in concept, relatively simple," said Dr. Herbert Engelhard, associate professor of neurosurgery and site investigator for the trial at UIC.

Following a baseline MRI to determine the location of the tumor, several electrodes are placed on the patient's shaved head. The electrodes are connected to a medical device with alternating electric fields powered by a portable battery. The patient remains on the portable device for 22 hours a day, indefinitely, while continuing his or her daily activities at home.

"Research has shown that these electrical fields rupture the cancer cells as they divide," Engelhard said.

While likely not a cure for the deadly tumor, called glioblastoma multiforme, the therapy, Engelhard says, may extend life for some people. In an earlier small-scale study, the therapy more than doubled survival for glioblastoma patients.

Glioblastoma multiforme is the most deadly of all intracranial tumors. Standard therapy does not provide a cure and often results in side effects that compromise a patient's quality of life. Despite attempts to improve outcome, the current three-year survival is only 6 percent.

"Patients with recurrent glioblastoma whose tumor progresses despite radiation treatment and chemotherapy do not have many options," Engelhard said. "Therefore, it's critical that we consider new therapies for the treatment of this disease."

Fifty-one-ye
'"/>




Page: 1 2

Related medicine news :

1. Researchers at Cornell University as been reported using research fund by false claims
2. A new study by John Hopkins University proposes formula for good health
3. James Cook University urges more medical seats
4. Pill splitting program of University of Michigan can save money
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Yale University guidelines for Physicians and Pharmaceutical industry
7. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
8. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
9. Hwang Woo Suk Suspended By Seoul National University
10. Vladeck to head the University of Medicine and Dentistry of New Jersey
11. Rice University wins Prestigious Grants from HHMI
Post Your Comments:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
...scientists from British Cardiac Society, the Briti...e Primary Care Cardiovascular Society // and the ...idelines for preventing cardiovascular risks of he.... The new guidelines is drafted to reduce the risk...
...tish Medical Journal it was said that people in Lo.../ . Money cannot bring you all the comforts and h...g the relationships that a happy and long life can...als usually get richer during their lifetimes – bu...
... Health & Science University and the University of...ct molecular mixture present in male-emitted phero...ity and increased aggression) dictates the sexual ...ompetitors and influences the female elephants mat...
...robably rosy picture of coma patients' survival an...s for viewers // , says a study. Tracking storylin...hers found that soap opera patients were far more ...e. And they were also much more likely to emerge u...
Other Medicine News:Health News:Happiness Is Not Attained By A Wealthy Life But By A Healthy One. 2Health News:The Chemistry Of Sexual Attraction Between Male And Female Elephants 2
(Date:10/3/2008)... REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/...ed the filing of an investigational new drug,(IND)...molecule modulator,of phosphodiesterase 4 (PDE4), ...e compound is being developed as a new and potenti...y loss and cognitive deficits associated,with Alzh...
(Date:10/2/2008)...The Study Will Compare the Results of Rosetta Geno...hich Differentiates Squamous From non Squamous ...tic Methods, A Test Based on the miRview(TM) Techn...olumbia University,s High Complexity Molecular Pat...Year, Rosetta Genomics is Expecting to Launch miR...
(Date:10/2/2008)... GOTEBORG, Sweden, October 2 /- Calab... dose study in xerostomia ("dry mouth"),patients h...studied in 45,dry mouth patients between the ages ...ct a dose for evaluation in a succeeding Phase III... the cholinesterase inhibitor,physostigmine. It is...
(Date:10/2/2008)... Data Indicate Dual Modes of Action and Synergy ...stCall/ -- Access Pharmaceuticals, Inc.,(OTC Bulle...clinical,studies on Angiolix showing that by block...nic effect as well as a direct anti-proliferative ... of human breast cancer (MX-1),Angiolix had a sig...
Breaking Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Pancreatic Cancer Biomarkers Found 21825 1Pancreatic Cancer Biomarkers Found 21825 2Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 1Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 230 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 130 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 2Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 1Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 2
...HMOND, Va.--(BUSINESS WIRE)--May 3, 2007 - Insmed ...s from a Phase II,investigator-sponsored study of ...otonic muscular dystrophy (DM1)., Preliminary resu...University of Rochester School of Medicine and Den...oses of IPLEX up to 1,mg/kg/day in six patients me...
...ding Symbol: QPT: TSX Venture Exchange, EDMONTON, ...Tech,Inc. ("Quest" or the "Company") Quest is plea...opment of SL052 for the treatment,of prostate canc...of cancer death in,American men with approximately...rent therapeutic modalities for localized prostate...
Other Medicine Technology:Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3
Bacon Bone Rongeur
Schell Rongeur
Zaufal-Jansen Ronguer
Ruskin Mini-Bone Rongeur
Medicine Products: